Slide 1: Recovery in elective surgery overshadowed by external challenges
Recovery in elective surgery overshadowed by external challenges Getinge Q2 2022 Mattias Perjos, CEO Lars Sandström, CFO
Slide 2: Key takeaways
Key takeaways Q2 2022 • Organic growth in elective surgery overshadowed by external challenges – leading to 5.0% and 7.5% organic decline in orders and net sales • Margins impacted by volume decline, mix and cost increases due to supply chain challenges and overall inflation pressure • Positive Free
Slide 3: Key activities and events
Key activities and events Q2 2022 Offering and customers Sustainability improvements • Acquisition of FLUOPTICS – supporting higher • Investments for climate neutral gas, solar panels and efficiency, safety and quality in advanced surgery geothermal heating system • DPTE®-EXO – supporting higher eff
Slide 4: Tough comps in ventilators, ECMO and DPTE-BetaBag in all regions
Tough comps in ventilators, ECMO and DPTE®-BetaBag in all regions Impacting the Y-o-Y comparisons negatively Global Americas EMEA APAC Organic Order Growth -5.0% Organic Net Sales Growth -7.5% Getinge │ Presentation │ Q2 Report 2022 July 19, 2022 Page 4
Slide 5: Outlook 2022
Outlook 2022 Organic net sales for 2022 expected to be in line with reported net sales in 2021 Getinge │ Presentation │ Q2 Report 2022 July 19, 2022 Page 5
Slide 6: Tough comps in all business areas and regions
Tough comps in all business areas and regions Order Intake Bridge Q2 2021 – Q2 2022 Organic change -7.1% -5.3% -1.2% -5.0% 148 31 133 7,246 6,934 MSEK Q2 2021 Acute Care Therapies Life Science Surgical Workflows Q2 2022 Getinge │ Presentation │ Q2 Report 2022 July 19, 2022 Page 6
Slide 7: Tough comps especially in Acute Care Therapies
Tough comps especially in Acute Care Therapies Net Sales Bridge Q2 2021 – Q2 2022 Organic change -17.7% 7.7% 7.6% -7.5% 273 144 MSEK -332 564 Currency impact, MSEK 6,587 6,670 Organic growth, % -5.4 Q2 2021 Acute Care Life Science Surgical Q2 2022 -10.8 Therapies Workflows Capital Recurring Goods Re
Slide 8: Lower volumes, unfavorable mix effects and higher costs impacting GM
Lower volumes, unfavorable mix effects and higher costs impacting GM Adjusted Gross Profit Bridge Q2 2021 – Q2 2022 Adj GM, % Q2 2022 58.9 37.4 41.7 50.3 (Q2 2021) (64.1) (41.6) (41.6) (55.0) Gross Margin impact -269 116 Volume 17 -401 Business Area mix MSEK Factory absorption 3,624 3,355 Supply cha
Slide 9: Financial development
Financial development Getinge │ Presentation │ Q2 Report 2022 July 19, 2022 Page 9
Slide 10: Adj EBITA margin negatively impacted by lower adj Gross Profit
Adj EBITA margin negatively impacted by lower adj Gross Profit Adjusted EBITA Bridge Q2 2021 – Q2 2022 19.0% 14.3% Margin development -5.8 pp Adj GP -294 -0.7 pp Adj OPEX -0.3 pp D&A 2.1 pp Currency 39 -269 -16 -113 -49 112 +212 MSEK 1,250 Currency impact, MSEK 956 Q2 2021 Adj Gross Adj Selling Adj
Slide 11: Positive free cash flow and still well below 100 WC days
Positive free cash flow and still well below 100 WC days Capital efficiency a priority Free CF impacted by reduced WC days well below 100 High Return on Invested Capital earnings and some build up of WC 160 140 120 1.4 16.4% 1.3 1.2 100 80 0.4 Q2 2022 0.1 0 Q2 2021 Q3 2021 Q4 2021 Q1 2022 Q4 2017 Q1
Slide 12: Solid financial position
Solid financial position Low net debt and high margin of safety when it comes to leverage Net debt is down significantly in recent years … … and leverage is signaling financial strength 14.0 3.4x 3.9 (1.2 BSEK excl. pension liabilities) 0.6 (0.2 x excluding pension liabilities) Q1 2019 Q2 2019 Q3 20
Slide 13: Summary
Summary Getinge │ Presentation │ Q2 Report 2022 July 19, 2022 Page 13
Slide 14: Key takeaways
Key takeaways Summary Q2 2022 • Recovery in elective surgery overshadowed by external challenges • Strengthened the offering • Margins impacted by volume decline, mix and cost increases due to supply chain challenges and overall inflation pressure • Positive Free Cash Flow • Solid financial position
Slide 15: Q&A
Q&A Getinge │ Presentation │ Q2 Report 2022 July 19, 2022 Page 15
Slide 16: Thank you
Thank you Getinge │ Presentation │ Q2 Report 2022 July 19, 2022 Page 16
Slide 17: Forward looking information
Forward looking information This document contains forward-looking information based on the current expectations of the Getinge’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectation
Slide 18: Getinge – Passion for Life
“= Se A GETINGE PASSION FOR LIFE